Výsledky vyhledávání - "Joel Sserubanja"

Does Intensive Treatment Select for Praziquantel Resistance in High-Transmission Settings? Parasitological Trends and Treatment Efficacy Within a Cluster-Randomized Trial

Autor: Alison M. Elliott, Jacent Nassuuna, Samuel Kiwanuka, Joel Sserubanja, Emily L. Webb, James Kaweesa, Paul L. A. M. Corstjens, Prossy Kabuubi, LaVIISWA Trial Team, Narcis B. Kabatereine, Lawrence Lubyayi, Govert J. van Dam, John Vianney Tushabe, Edridah M. Tukahebwa, Richard E. Sanya, William Ssenyonga, Elson Abayo

Publikováno v: Open Forum Infectious Diseases
Open Forum Infectious Diseases, 7(4). OXFORD UNIV PRESS INC

Background Praziquantel mass drug administration (MDA) is recommended in schistosomiasis-endemic areas. Animal models demonstrate Schistosoma parasite resistance to praziquantel after repeated exposure. Methods We conducted a parasitological survey i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab61bcdf78db568c7f366507d4967fa5
http://europepmc.org/articles/PMC7148002

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vyhledávací nástroje:

Upřesnit hledání